首页> 外文期刊>British Journal of Radiology >Cumulative patient effective dose in cardiology.
【24h】

Cumulative patient effective dose in cardiology.

机译:累积患者有效剂量的心脏病学。

获取原文
获取原文并翻译 | 示例
           

摘要

Medical radiation from X-rays and nuclear medicine is the largest non-natural (man-made) source of radiation exposure in Western countries. The aim of this study was to assess the individual cumulative effective dose in patients admitted to our cardiology ward. We collected a cumulative radiological history from a structured questionnaire and access to hospital records in 50 consecutive adult patients (36 males; age, 66.7+/-10.8 years) admitted to the Institute of Clinical Physiology in Pisa. The cumulative effective dose was assessed as an indicator of stochastic risk of cancer. We derived the effective dose for each individual examination from the Medical Imaging Guidelines of the European Commission (2001). On average, each patient underwent a median of 36 examinations (interquartile range, 23-46). The median cumulative effective dose was 60.6 mSv. Three types of procedures were responsible for approximately 86% of the total collective effective dose: (i) arteriography and interventional cardiology (12% of examinations, 48% of average dose per patient); (ii) nuclear medicine (5% of examinations, 21% of average dose per patient); and (iii) CT (4% of examinations, 17% of average dose per patient). The median estimated extra risk of cancer was approximately 1 in 200 exposed subjects. In conclusion, the average contemporary cardiological patient is exposed to a significant cumulative effective dose from diagnostic and therapeutic interventions. It is important to log cumulative dose for each patient at the time of each examination. Every effort should be made to justify the indications and to optimize the doses.
机译:来自X射线和核医学的医疗辐射是西方国家最大的非天然(人造)辐射暴露源。本研究的目的是评估患者录取的患者的个体累积有效剂量。我们从结构化问卷中收集了累积的放射性历史,并在连续50名成年患者(36名男性;年龄,66.7 +/- 10.8岁)中获得医院记录,录取了比萨临床生理学研究所。评估累积有效剂量作为癌症随机风险的指标。我们从欧盟委员会的医学成像指南(2001年)中源事的有效剂量。平均而言,每位患者经历了36项检查的中位数(四分位数范围,23-46)。中位数累积有效剂量为60.6msV。三种类型的程序负责总集体有效剂量的约86%:(i)动脉造影和介入心脏病学(12%的考试,每个患者平均剂量的48%); (ii)核医学(5%的考试,每位患者平均剂量的21%); (iii)CT(4%的考试,每位患者平均剂量的17%)。中位数估计癌症的额外风险大约是200个暴露的受试者。总之,平均当代心脏病学患者暴露于诊断和治疗干预措施的显着累积有效剂量。在每次检查时对每位患者进行累积剂量对数量的影响非常重要。应尽一切努力来证明指示和优化剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号